Skip to main content
Equibles
WOOF logo

WOOF · Petco Health & Wellness Company, Inc. · Metrics

Track WOOF — free

Use WOOF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WOOF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.53 +0.22 (+9.52%) At close · Oct 22
Russell 2000 member Rebalance outlook locked
Market Cap
$795.94M
Shares
324.21M
Volume · Oct 22 4.84M Avg daily vol (3M) 2.32M

WOOF metrics

100 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.53
Market cap
$795.94M

Price action

20 metrics
Price change (1W)
+6.1%
Price change (30D)
+5.9%
Price change (3M)
-0.4%
Price change (6M)
-15.4%
Price change (YTD)
-10.0%
Price change (1Y)
-31.4%
Trailing year
Price change (5Y)
-89.3%
52-week high
$3.82
52-week low
$2.18
Change from 52-week high
-33.8%
Change from 52-week low
+16.1%
Annualized volatility
60.7%
Annualized volatility (3M)
47.6%
Beta
0.8
RSI (14D)
63.1
Price vs SMA 50
+2.2%
Price vs SMA 200
-5.7%
Avg volume (3M)
2.32M
Relative volume
2.1
Average dollar volume
$5.83M

Company

3 metrics
Sector
Consumer Cyclical
Industry
Specialty Retail
Shares outstanding
324.21M

Valuation

12 metrics
P / E (TTM)
25.3
Trailing earnings · reciprocal yield 4.0%
PEG ratio
0.2
EV / revenue
0.3×
reciprocal yield 301.6%
EV / EBITDA
6.0×
reciprocal yield 16.7%
EV / EBIT
14.8×
reciprocal yield 6.7%
P / sales
0.1×
reciprocal yield 749.5%
P / book
0.7
reciprocal yield 151.6%
FCF yield
29.9%
TTM · current market cap
Buyback yield
—
P / FCF
3.3
reciprocal yield 29.9%
P / operating cash flow
2.1
reciprocal yield 47.0%
Earnings yield
3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.4×
reciprocal yield 251.0%
EV / revenue historical average (5Y)
0.6×
reciprocal yield 176.4%
EV / EBIT historical average (3Y)
71.8×
reciprocal yield 1.4%
EV / EBIT historical average (5Y)
46.7×
reciprocal yield 2.1%
EV / EBITDA historical average (3Y)
9.4×
reciprocal yield 10.7%
EV / EBITDA historical average (5Y)
10.3×
reciprocal yield 9.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-02

Profitability

9 metrics
Gross margin
38.8%
Operating margin
2.2%
Trailing 12 months
Net margin
0.5%
Gross profit (TTM)
$2.32B
Operating profit (TTM)
$133.49M
Net income (TTM)
$30.27M
Trailing 12 months
Diluted EPS (TTM)
$0.10
FCF margin
4.0%
Effective tax rate
-43.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$20.65
Gross profit per diluted share (TTM)
$8.02
Operating profit per diluted share (TTM)
$0.46
EBITDA per diluted share (TTM)
$1.14
Net income per diluted share (TTM)
$0.10
Operating cash flow per diluted share (TTM)
$1.28
Free cash flow per diluted share (TTM)
$0.81
Capital expenditures per diluted share (TTM)
$0.47
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.11
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+0.0%
Year over year
Net income growth YoY
+176.7%
Revenue (TTM)
$5.97B
Trailing 12 months
EPS growth YoY
+160.0%
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
-0.4%
Revenue CAGR (5Y)
+3.9%
EPS CAGR (3Y)
-55.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+40.1%
FCF CAGR (5Y)
+11.4%

Quality

14 metrics
Return on equity
2.5%
Return on assets
0.6%
Debt / equity
1.2
Current ratio
0.9
EBITDA (TTM)
$330.47M
Free cash flow (TTM)
$237.83M
Quick ratio
0.4
Interest coverage
1.0
Net debt / EBITDA
3.6
Return on invested capital
—
Trailing 12 months
Net cash
−$1.18B
Latest balance sheet
Cash & equivalents
$293.50M
Total assets
$5.17B
Total debt
$1.48B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$374.20M
Capital expenditures (TTM)
$136.37M
R&D (TTM)
—
SG&A (TTM)
$2.18B
Stock compensation (TTM)
$32.49M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

9 metrics
13F filers
198
13F filer change QoQ
-7
Institutional ownership
93.0%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.5%
Holder tenure
12.9
Price vs estimated holder cost
-78.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
5.1%

Short interest

3 metrics
Short interest
5.9%
Latest settlement · 9.6 days to cover
Days to cover
9.6d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1826470 CUSIP 71601V105 13F (30d) 22 filings 22 filers Visit website Investor relations